SPECIAL REPORT: AusCann has benefited from a wave of interest in medicinal cannabis for pain relief to be the BN30’s top performer in shareholder returns for the year to June 30.
09/07/2018 - 15:57
Strong returns for AusCann investors
09/07/2018 - 15:57
